LN-364432
CP 66713 , NLT 98% , 91896-57-0
Synonym(s):
8-chloro-1-phenyl-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine;PF-1716311
Update time: 2023-04-23
PRODUCT Properties
| Density | 1.54±0.1 g/cm3(Predicted) |
| storage temp. | 2-8°C |
| solubility | DMSO: ≥5mg/mL |
| pka | 0.68±0.30(Predicted) |
| form | powder |
| color | white to off-white |
Description and Uses
CP-66713 is a selective adenosine A2 receptor antagonist, with Ki of 22 nM. CP-66713 inhibits induction of long-term potentiation of evoked synaptic potentials. CP-66713 can be used in the study of neurological diseases[1].
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P305+P351+P338 |
| Hazard Codes | Xn |
| Risk Statements | 22-36/37/38 |
| Safety Statements | 26 |
| WGK Germany | 3 |